Skip to content

Melanie A. Babinski, MDCM

NPI 1053001123ActiveIndividual· Pediatrics, Pediatric Endocrinology· Boston, MA

Pediatrics, Pediatric Endocrinology (MDCM) in Boston, Massachusetts, trained at McGill University, Faculty of Medicine (class of 2020). Enrolled in Medicare as practitioner - endocrinology. Novo Nordisk Inc reported $82.37 in payments in 2025, mostly food and beverage.

Overview

NPI1053001123
StatusActive
Entity typeIndividual
CredentialMDCM
Sole proprietorNo
NPI issuedMay 11, 2023
Last updated in NPPESJul 7, 2026
Certified by providerJul 7, 2026

Specialties and licenses

TaxonomyCodeLicenseState
Pediatrics, Pediatric Endocrinology Primary2080P0205X1014912MA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Endocrinology (MA)

Medicare sources and data years

Education and affiliations

Medical schoolMcGill University, Faculty of Medicine
Graduation year2020
Medicare specialtyEndocrinology

Medical group

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$82.37 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Novo Nordisk Inc$82.371

What the 2025 payments were for

  • Food and Beverage$82.37 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Pediatrics, Pediatric Endocrinology providers in Boston

All Pediatrics, Pediatric Endocrinology providers in Massachusetts →